61890-25-3 Usage
General Description
1-phenyl-2-(pyridin-2-yl)ethanamine, also known as 2-Phenyl-2-(pyridin-2-yl)ethylamine, is a chemical compound that belongs to the class of arylalkylamines. It is a derivative of phenethylamine and pyridine, with a molecular formula C16H16N2 and a molecular weight of 240.31 g/mol. 1-phenyl-2-(pyridin-2-yl)ethanamine is commonly used in organic synthesis and pharmaceutical research, and it has been investigated for its potential biological activities, including its role as a neurotransmitter or neuromodulator in the central nervous system. Its chemical structure and properties make it a valuable tool in medicinal chemistry and drug discovery, as well as a target for studying the structure-activity relationships of related compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 61890-25-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,9 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 61890-25:
(7*6)+(6*1)+(5*8)+(4*9)+(3*0)+(2*2)+(1*5)=133
133 % 10 = 3
So 61890-25-3 is a valid CAS Registry Number.
61890-25-3Relevant articles and documents
Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
-
, (2008/06/13)
There is provided a method of treatment of neurological disorders, such as epilepsy, stroke and cerebral ischaemia, which comprises the administration of a compound of Formula I: STR1 wherein, Ar1 and Ar2, which may be the same or different, independently represent phenyl or phenyl substituted by one or more of amino, nitro, halogen, hydroxy, C1 to 6 alkoxy, C1 to 6 alkyl or cyano; R1 represents hydrogen, C1 to 6 alkyl, C1 to 6 alkoxycarbonyl; R2 represents hydrogen or COCH2 NH2 ; R3 represents hydrogen or C1 to 6 alkyl; in addition, when R2 represents hydrogen either one or both of Ar1 and Ar2 may also represent 2-, 3- or 4-pyridinyl and R1 may also represent trihalomethyl; or a pharmaceutically acceptable salt thereof. Some of the compounds of formula I are novel, and these are also provided, together with pharmaceutical compositions containing the novel compounds.